Evidence map›Paper›PMID 29391442›Full record

ArticleScientific reports2018

Deep vein thrombosis in mice is regulated by platelet HMGB1 through release of neutrophil-extracellular traps and DNA.

Mitchell R Dyer, Qiwei Chen, Shannon Haldeman, Hamza Yazdani, Rosemary Hoffman, Patricia Loughran, Allan Tsung, Brian S Zuckerbraun, Richard L Simmons, Matthew D Neal

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 154 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Immune cell-mediated venous thrombus resolution.Research and practice in thrombosis and haemostasis · 2023
    Review

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Mitchell R DyerDepartment of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Qiwei ChenDepartment of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Shannon HaldemanDepartment of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Hamza YazdaniDepartment of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Rosemary HoffmanDepartment of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Patricia LoughranDepartment of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-9375-1724
Allan TsungDepartment of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Brian S ZuckerbraunDepartment of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Richard L SimmonsDepartment of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Matthew D NealDepartment of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. nealm2@upmc.edu.
University of Pittsburgh Medical Center · USUniversity of Pittsburgh · US

Funding

Multi-Center Group to Study Acute Liver Failure in ChildU01DK072146 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SQUIRES, ROBERT H · 2005 to 2014
$23.2M
Mechanistic Elucidation and Targeted Therapy of Platelet Dysfunction After TraumaR35GM119526 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NEAL, MATTHEW D · 2016 to 2025
$3.9M
NIDDK NIH HHS U01 DK072146NIGMS NIH HHS R35 GM119526
6 · The paper itself

Abstract

Venous thromboembolic (VTE) disease, consisting of deep venous thrombosis (DVT) and pulmonary embolism (PE) is a leading cause of morbidity and mortality. Current prophylactic measures are insufficient to prevent all occurrence in part due to an incomplete understanding of the underlying pathophysiology. Mounting evidence describes interplay between activation of the innate immune system and thrombus development. Recent work has demonstrated that platelet release of HMGB1 leads to increased microvascular complications following injury. Additionally, platelet HMGB1 was found to enhance DVT and increase the formation of neutrophil extracellular traps (NETs), although the role of HMGB1 induced NET release in thrombosis remains unexplored. Utilizing a transgenic mouse lacking HMGB1 specifically from platelets and megakaryocytes we now demonstrate the specific role of platelet-derived HMGB1 in acute and subacute/chronic venous thrombosis. Platelets account for the majority of circulating HMGB1 and HMGB1 deposition within the developing clot. The pro-thrombotic effect of platelet-derived HMGB1 is mediated through enhanced neutrophil recruitment, NET formation and specifically release of extracellular DNA during NET formation. Taken together, these data suggest that platelet HMGB1 mediated NET release is a primary regulator of DVT formation in mice.

Indexed as

AnimalsBlood PlateletsCells, CulturedDNAExtracellular TrapsHMGB1 ProteinMaleMiceMice, Inbred C57BLNeutrophilsVenous ThrombosisDNAHMGB1 ProteinHMGB1 protein, mouse

Identifiers

PMID29391442
PMCPMC5794752
OpenAlexW2807578948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.